Fc-Tagged Extracellular Vesicles for High-Purity Affinity Isolation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for isolating extracellular vesicles suffer from low purity and efficiency, requiring labor-intensive and costly processes.

Innovation Solution

The use of a fusion protein comprising an extracellular vesicle membrane protein and an immunoglobulin Fc region or variant thereof, allowing for high-purity isolation through affinity chromatography.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If current isolation methods (ultracentrifugation, density gradient centrifugation, etc.) are used, then extracellular vesicles can be isolated, but the purity and isolation efficiency are relatively low and the process is labor-intensive

Engineering Contradiction:
Improvepurity of isolated extracellular vesiclesVSAvoidisolation efficiency of extracellular vesicles
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The patent introduces a fusion protein comprising an extracellular vesicle membrane protein and an immunoglobulin Fc region as an intermediary. This fusion protein enables specific binding between extracellular vesicles and protein ligands (such as Protein A or Protein G) through the Fc region, allowing for high-purity isolation via affinity chromatography while significantly improving isolation efficiency and reducing labor requirements

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent creates a composite structure by fusing the extracellular vesicle membrane protein with the immunoglobulin Fc region. This composite fusion protein combines the properties of both components: the membrane protein ensures specific association with extracellular vesicles while the Fc region provides high-affinity binding to protein ligands, enabling efficient and pure isolation

Inventive Principle:
Principle #40Composite materials

2Quantity of substance

If current isolation methods are used, then extracellular vesicles can be isolated, but significant time and cost are required

Engineering Contradiction:
Improveamount of isolated extracellular vesiclesVSAvoidtime required for isolation process
Core Design Contradiction:
Quantity of substanceVSLoss of time

Solution Approach 1:

The fusion protein acts as a mediator that enables rapid and specific capture of extracellular vesicles through affinity chromatography. The protein ligand-bound matrix selectively binds extracellular vesicles expressing the Fc-fused membrane protein, allowing for fast isolation in a single step without the time-consuming sequential processes of traditional methods

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes the surface properties of extracellular vesicles by introducing the Fc region, which fundamentally alters their isolation characteristics. This modification enables the use of affinity-based isolation parameters (specific binding to protein ligands) rather than physical separation parameters (centrifugal force, density gradients), dramatically reducing isolation time

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Extracellular vesicles are isolated with high purity and efficiency using affinity chromatography, facilitating their application in disease diagnosis and treatment.

Implementation Method 1

the affinity of the Fc region with a protein ligand

Methodology Applied
Scientific EffectAffinity: Absorption (physical)

Data Source

PatentEP4707297A1Recombinant extracellular vesicles containing immunoglobulin FC region or variant thereof and method for isolating extracellular vesicles using same
Publication Date: 2026.03.11 INEXOPLAT INC
  • EP4707297A1 patent drawingFigure 1a
  • EP4707297A1 patent drawingFigure 1b
  • EP4707297A1 patent drawingFigure 2a

AI summary

The present invention relates to recombinant extracellular vesicles comprising an immunoglobulin Fc region or a variant thereof, and a method for isolating extracellular vesicles using the same. By utilizing the affinity between the immunoglobulin Fc region and specific protein ligands, extracellular vesicles can be isolated with high purity and efficiency. The extracellular vesicles can be isolated with high purity by the simple and straightforward method affinity chromatography, and thus is highly apt to be advantageously applicable in the diagnosis and treatment of various diseases.